Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Income from Continuing Operations (2016 - 2025)

Marimed has reported Income from Continuing Operations over the past 15 years, most recently at 4641000.0 for Q4 2025.

  • Quarterly Income from Continuing Operations rose 43.84% to 4641000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 14272000.0 through Dec 2025, down 17.13% year-over-year, with the annual reading at 14456000.0 for FY2025, 16.3% down from the prior year.
  • Income from Continuing Operations was 4641000.0 for Q4 2025 at Marimed, down from 2941000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 7589000.0 in Q2 2021 and troughed at 10128000.0 in Q4 2023.
  • The 5-year median for Income from Continuing Operations is 1130000.0 (2024), against an average of 1061050.0.
  • Year-over-year, Income from Continuing Operations surged 764.98% in 2021 and then tumbled 319.5% in 2025.
  • A 5-year view of Income from Continuing Operations shows it stood at 6398000.0 in 2021, then surged by 174.23% to 4749000.0 in 2022, then crashed by 313.27% to 10128000.0 in 2023, then increased by 18.4% to 8264000.0 in 2024, then soared by 43.84% to 4641000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Income from Continuing Operations are 4641000.0 (Q4 2025), 2941000.0 (Q3 2025), and 1270000.0 (Q2 2025).